Neuroprotective Serotonin 2A Receptor Peptide Significantly Reduced Hippocampal Inflammation in Rats Exposed to Mild...

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Traumatic brain injury (TBI) often leads to persistent neurological deficits due to neuroinflammation.
• The serotonin 2A receptor plays a role in the brain's response to injury.

Purpose of the Study:

• To investigate the anti-inflammatory effects of SN..8, a peptide mimic of the serotonin 2A receptor, in a rat model of TBI.
• To determine if SN..8 administration suppresses hippocampal inflammation post-TBI.

Main Methods:

• Adult male Sprague-Dawley rats underwent lateral fluid percussion (LFP)-induced TBI or sham injury.
• The peptide SN..8 or a scrambled sequence (LD..8) was administered intraperitoneally at 1, 3, and 5 days post-injury.
• Hippocampal gene expression, specifically CD68 mRNA, was analyzed via RT-PCR two weeks after injury.

Main Results:

• SN..8 significantly reduced CD68 mRNA expression (a marker of inflammation) by over 3-fold in the ventral hippocampus of TBI rats compared to the scrambled peptide group.
• This reduction was observed in the subacute phase, two weeks post-TBI.

Conclusions:

• The SN..8 peptide demonstrates significant anti-inflammatory effects in the ventral hippocampus following TBI in rats.
• These findings suggest that SN..8 may possess neuroprotective properties by suppressing subacute neuroinflammation, potentially mitigating long-term neurological impairment.